Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants.
Incomplete release and poor stability of encapsulated proteins are common hurdles to overcome when developing poly(lactide-co-glycolide) (PLGA) controlled-release systems. Antacid excipients such as Mg(OH)2, which increase both microclimate pH and polymer water uptake, have been shown to prevent acid-induced instability of proteins encapsulated in PLGA. The purpose of this study was to delineate the effects of microclimate pH and polymer water content on the stability of encapsulated bovine serum albumin (BSA) by comparing the effects of Mg(OH)2 with those of another excipient, sucrose, which increases polymer water content without significantly affecting acid-base chemistry of the polymer. These two excipients, when encapsulated in PLGA at appropriate levels (3% Mg(OH)2 vs. 10% sucrose), were found to cause identical water sorption kinetics, thus allowing the effect of the two microclimate parameters to be determined. In contrast to their similar effects on polymer water sorption, Mg(OH)2 afforded a much greater stabilization effect on encapsulated BSA than did sucrose, with less than 7% aggregates for 3% Mg(OH)2 compared to 51% for 10% sucrose and 81% without either excipient after 4 weeks of incubation at 37 degrees C. When the protein stabilization rationale of neutralizing the acidic microenvironment by adding Mg(OH)2 was applied to the delivery of an important therapeutic protein, tissue plasminogen activator (t-PA), t-PA stability was also improved and the active protein was completely recovered during a one month period of in vitro release. These data demonstrated that although increased water uptake induced by antacid excipients may improve the stability of the encapsulated proteins, the homogeneous acid neutralization effect is unique to antacid excipients such as Mg(OH)2, which is necessary to maintain the stability of proteins in acidic PLGA specimens.
Kang
Jichao
J
Department of Pharmaceutical Sciences, The University of Michigan, Ann Arbor 48109-1065, USA.
Schwendeman
Steven P
SP
D004343:Drug Implants; D019344:Lactic Acid / Q000008:administration & dosage*; D008276:Magnesium Hydroxide / Q000737:chemistry*; D008855:Microscopy, Electron, Scanning; D011100:Polyglycolic Acid / Q000008:administration & dosage*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000008:administration & dosage*; D012710:Serum Albumin, Bovine / Q000737:chemistry*; D013395:Sucrose / Q000737:chemistry*; D014867:Water / Q000737:chemistry
D004343:Drug Implants; D011108:Polymers; D014867:Water; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D012710:Serum Albumin, Bovine; D019344:Lactic Acid; D013395:Sucrose; D008276:Magnesium Hydroxide